中文速读
本研究探讨Tau过表达通过破坏线粒体稳态导致心肌肥厚,使用Enlight™ Western Blot Substrate(Engreen)进行Western blot检测相关蛋白表达。
质粒DNA
本文使用:增强型ECL发光液Enlight™
Tau Overexpression Causes Cardiac Hypertrophy by Disrupting Mitochondrial Homeostasis.
Affiliations
- 1 State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing 102206, China.
- 2 College of Life Sciences, Hebei University, Baoding 071002, China.
- PMID: 42794506
- DOI: 10.3390/ijms27188075
Abstract
Tau is classically defined as a microtubule-associated protein whose dysfunction underpins neurodegenerative disorders. However, its role in cardiac pathophysiology remains elusive despite recent evidence of its cardiac expression. Here, we report that a ~55 kDa Tau-immunoreactive species, which is commonly found in the nervous system, is markedly upregulated in isoproterenol-induced hypertrophic murine hearts, suggesting that this stress-inducible species is associated with maladaptive cardiac remodeling. Forced Tau expression was sufficient to induce hypertrophic growth in cultured cardiomyocytes. Cardiomyocyte-restricted Tau overexpression in transgenic mice recapitulated the progressive trajectory from hypertrophy to overt heart failure. Mechanistically, Tau overexpression triggered excessive mitochondrial fission, leading to mitochondrial dysfunction evidenced by reduced mitochondrial membrane potential, elevated reactive oxygen species, diminished activity of respiratory chain complexes I and IV, and decreased intracellular ATP. Pharmacological inhibition of mitochondrial fission with Mdivi-1 attenuated Tau overexpression-induced cardiomyocyte hypertrophy; taken together, our gain-of-function evidence identifies the ~55 kDa Tau-immunoreactive species as a stress-associated factor that disrupts mitochondrial dynamics to promote cardiac remodeling, and suggests Tau as a potential therapeutic target for cardiac diseases.
Keywords: Cardiac hypertrophy; Tau; therapeutic target; Mitochondrial Homeostasis
https://doi.org/10.3390/ijms27188075
增强型ECL发光液Enlight™ 已有 166 篇已发表文献
同类研究
- J Transl Med. 2026 Mar 26;24(1):630.doi: 10.1186/s12967-026-08050-z. CPNE1: A novel therapeutic target for myopia progre…
- Alzheimers Res Ther. 2026 Feb 19;18(1):66.doi: 10.1186/s13195-026-01990-0. Upregulation of SLC38A2 by melatonin attenuat…
- Acta Pharmacol Sin. 2026 Feb;47(2):493-503.doi: 10.1038/s41401-025-01663-y.TNFSF15 alleviates myeloid-derived suppressor…
- Adv Sci (Weinh). 2026 Jan;13(3):e10782.doi: 10.1002/advs.202510782. Epub 2025 Oct 30. FXYD3 Promotes Tumor Progression b…
- Mol Neurobiol. 2025 Nov 7;63(1):12.doi: 10.1007/s12035-025-05489-x. Resveratrol Attenuates H2O2-induced Aging and Apopto…
